Literature DB >> 3873069

An endothelial cell-dependent pathway of coagulation.

D Stern, P Nawroth, D Handley, W Kisiel.   

Abstract

Although the endothelial cell is considered antithrombogenic, endothelium has recently been shown to participate in procoagulant reactions. In this report cultured bovine aortic endothelial cells are shown to propagate a procoagulant pathway starting with factor XIa, leading to activation of factors IX, VIII, X, and prothrombin, culminating in fibrinopeptide A cleavage from fibrinogen and formation of a fibrin clot. Electron microscopic studies demonstrated that fibrin strands are closely associated with the endothelial cells. Endotoxin-treated endothelial cells, having acquired tissue factor activity, generated fibrinopeptide A in the presence of factors VIIa, IX, VIII, X, prothrombin, and fibrinogen. Factor X activation by factor VIIa and tissue factor expressed by endothelial cells is 10 times greater in the presence of factors IX and VIII than in their absence. This indicates that on the perturbed endothelial cell surface, factors IX and VIII do have an important role in the activation of factor X. Addition of platelets (10(8) per ml) augmented thrombin formation seen in the presence of endothelium alone by about 15-fold. Anti-human factor V IgG decreased this enhanced thrombin formation in the presence of platelets, indicating that factor V from platelets was playing an important role in thrombin formation. These data lead us to propose that endothelial cells can actively participate in procoagulant reactions. Although platelets can augment thrombin formation by these endothelial cell-dependent reactions, endothelial cells alone can lead to formation of a cell-associated fibrin clot. The endotoxin-treated endothelial cell provides a model of the thrombotic state supplying tissue factor to initiate coagulation and propagating the reactions leading to fibrin formation. This endothelial cell-dependent pathway suggests a central role for factors VIII and IX consistent with their importance in hemostasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873069      PMCID: PMC397591          DOI: 10.1073/pnas.82.8.2523

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Prothrombin.

Authors:  K G Mann
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

3.  Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor).

Authors:  W Kisiel; K Fujikawa; E W Davie
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

Review 4.  Use of staphylococcal protein A as an immunological reagent.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Binding of bovine coagulation factor Xa to platelets.

Authors:  B Dahlbäck; J Stenflo
Journal:  Biochemistry       Date:  1978-11-14       Impact factor: 3.162

6.  New substrates for the radioassay of angiotensin converting enzyme of endothelial cells in culture.

Authors:  J W Ryan; A Chung; L C Martin; U S Ryan
Journal:  Tissue Cell       Date:  1978       Impact factor: 2.466

7.  A monoclonal IgG4 (lambda) with factor V inhibitory activity.

Authors:  P E Hurtubise; M C Coots; D J Jacob; A F Muhleman; H I Glueck
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

8.  Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.

Authors:  B B Weksler; A J Marcus; E A Jaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

9.  Interaction of coagulation factor Xa with human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  The measurement of thrombin in clotting blood by radioimmunoassay.

Authors:  M A Shuman; P W Majerus
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  36 in total

1.  A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin.

Authors:  L Y Bourguignon; V B Lokeshwar; J He; X Chen; G J Bourguignon
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 2.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Interaction of vitamin-K-dependent coagulation factors and the endothelium.

Authors:  P P Nawroth; D M Stern
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

4.  New insights into the spatiotemporal localization of prothrombinase in vivo.

Authors:  Lacramioara Ivanciu; Sriram Krishnaswamy; Rodney M Camire
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

5.  Microvascular injury and repair in acute human bacterial pyelonephritis.

Authors:  B Iványi; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  New in vivo model to assess venous endothelial cell functions. Effect of defibrotide.

Authors:  T Di Perri; F Laghi Pasini; C Frigerio; P L Capecchi; G L Messa; M Franchi; F Landini; A Burresi; A Ghezzi; L Ceccatelli
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester.

Authors:  G Archipoff; A Beretz; J M Freyssinet; C Klein-Soyer; C Brisson; J P Cazenave
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

9.  Constitutive repression of interleukin-1alpha in endothelial cells.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2008-02-21       Impact factor: 17.367

Review 10.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.